Dr. Ouri Fischel, PhD, MBA

Business Development Director

Dr. Ouri Fischel (PhD, MBA), Business Development Director at BioXL, specializes in drug discovery and development. He has extensive experience working on protein kinase inhibitors for cancer treatment in collaboration with Sanofi-Aventis and Janssen Pharmaceutica (Johnson & Johnson).With a PhD in Pharmacology and an MBA in Biomedical Management, Dr. Fischel combines scientific expertise with strong business acumen. He has successfully raised funding for companies focused on Rational Drug Design, Cheminformatics, and Machine Learning, positioning him as a key contributor to BioXL’s strategic initiatives and growth.